#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Raynaud's phenomenon Immunoglobulin G4 related disease T-cell type acute leukaemia Desmoplastic small round cell tumour Univentricular heart Extra-osseous Ewing's sarcoma metastatic Metabolic disorder Adenomatous polyposis coli Dermatitis Rectal cancer Ureteric cancer Ductal adenocarcinoma of pancreas Chronic myeloid leukaemia Atypical haemolytic uraemic syndrome Cushing's syndrome More trials…

    Learn about Rare Diseases

    KBG syndrome – Treatment Mantle cell lymphoma refractory – Life with Disease Rhabdomyosarcoma recurrent – Trials in Disease Marfan’s syndrome Medulloblastoma – Diagnostics Hereditary neuropathic amyloidosis – Trials in Disease VEXAS syndrome – Trials in Disease Progressive supranuclear palsy – Life with Disease Lennox-Gastaut syndrome – Treatment Basal cell naevus syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HUMAN COAGULATION FACTOR XIII Itolizumab Fluconazole Ribonucleic Acid K10 Bezafibrate Avibactam Elezanumab Vosilasarm Ceftriaxone Sodium Marstacimab Rezpegaldesleukin Calcium Oxybate Vamorolone Glofitamab Trastuzumab Emtansine Oxacillin Specific Nucleic Acid Sna-Xfsa Datopotamab Deruxtecan Letermovir Azd3427 More therapies…

    Learn about Your Condition

    Corticobasal degeneration Corneal dystrophy Hypophosphatasia Bladder cancer stage III Trigeminal neuralgia Large cell lung cancer Supraventricular tachycardia Hypersensitivity Ichthyosis Pulmonary alveolar haemorrhage Coma Pancreatitis acute Osteonecrosis of jaw Primary biliary cholangitis Neurodegenerative disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Amoxicillin and Potassium Clavulanate for Preventing Anal Fistula in Patients After First Perianal Abscess Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Anal abscess
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • POTASSIUM CLAVULANATE
    Spain

  • Study on the Effect of Methylprednisolone Injection for Reducing Swelling, Stiffness, and Pain After Lower Wisdom Tooth Surgery in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Post procedural complication
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    Hungary

  • Study on the Effects of TOUR006 for Adults with Thyroid Eye Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • HUMAN IGG2 MONOCLONAL ANTIBODY AGAINST IL-6
    France Italy Latvia Poland Slovakia Spain

  • Study on the Effectiveness of N-Acetylcysteine and Methylprednisolone for Patients with Severe Acute Alcoholic Hepatitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Acetylcysteine
    • Lidocaine Hydrochloride Monohydrate
    • Methylprednisolone Acetate
    Spain

  • Study of Ivosidenib, Durvalumab, and Gemcitabine/Cisplatin for Patients with Advanced Cholangiocarcinoma with IDH1 Mutation

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Cisplatin
    • Durvalumab
    • Gemcitabine
    France Germany Spain

  • Study on Airway Changes in Patients with Residual Neuromuscular Blockade Using Sugammadex and Rocuronium Bromide

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Rocuronium Bromide
    • Sugammadex
    Hungary
Previous Page
1 … 804 805 806 807 808 … 1,659
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!